Top Factor Driving CRISPR Gene Editing Market Growth in 2025: Genetic Disorder Prevalence Fuels The CRISPR Gene Editing Market Growth

What combination of drivers is leading to accelerated growth in the crispr gene editing market?
The rising prevalence of genetic disorders is expected to drive the growth of the CRISPR gene-editing market. Genetic disorders, caused by mutations in genes or chromosomes, are increasing due to genetic factors, aging populations, and consanguineous marriages. CRISPR technology is used to edit genes and correct mutations, providing potential treatments for genetic disorders like cystic fibrosis. For example, the Cystic Fibrosis Foundation reported in July 2022 that nearly 40,000 people in the US were living with cystic fibrosis. Therefore, the increasing incidence of genetic disorders is propelling the growth of the CRISPR market.

Get Your CRISPR Gene Editing Market Report Here:
https://www.thebusinessresearchcompany.com/report/crispr-gene-editing-global-market-report

What is the projected compound annual growth rate (CAGR) of the crispr gene editing market from 2025 to 2034, and what factors influence it?
The CRISPR gene editing market has seen exponential growth in recent years. It will grow from $2.26 billion in 2024 to $2.88 billion in 2025, with a CAGR of 27.4%. The rise in government funding, increased cancer cases, growing chronic disease prevalence, greater awareness of CRISPR technology, and advancements in healthcare infrastructure have fueled this growth.

The CRISPR gene editing market is expected to expand exponentially, reaching $7.51 billion by 2029 at a CAGR of 27.1%. The market is driven by the increasing prevalence of genetic disorders, the rise of precision medicine, investments in CRISPR research, an aging population, and the growing focus on gene therapy. Major trends include advancements in gene editing technology, more research studies, drug development, improved delivery methods, and CRISPR-edited agriculture adoption.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15549&type=smp

How are the latest trends influencing the growth of the crispr gene editing market?
Companies in the CRISPR gene editing market are focusing on gene therapy to expand their customer base and boost revenue. Gene therapy uses genes to treat or prevent diseases. In December 2023, the US FDA approved Casgevy, a CRISPR/Cas9-based gene therapy for treating sickle cell disease. This therapy modifies hematopoietic stem cells using CRISPR/Cas9 technology to address the genetic mutation causing the disease.

What are the major segments of the crispr gene editing market and their role in driving growth?
The CRISPR gene editing market covered in this report is segmented -

1) By Type: CRISPR-Associated Nuclease (Cas Nuclease), Guide Ribonucleic Acid (RNA), Deoxyribonucleic Acid (DNA) Ligase, Restriction Endonuclease, Other Types
2) By Services: Design Tools, Plasmid And Vector, CRISPR-Associated Protein 9 (Cas9) And Guide Ribonucleic Acid (g-RNA), Delivery System Products, Other Services
3) By Technology: CRISPR Or Cas9, Zinc Finger Nucleases, Other Technologies
4) By Application: Agricultural, Biomedical, Industrial, Genome Engineering, Disease Models, Functional Genomics, Other Applications
5) By End User: Academic Institutes And Research Centers, Biotechnology Companies, Contract Research Organizations (CROs), Pharmaceutical And Biopharmaceutical Companies

Subsegments:
1) By CRISPR-Associated Nuclease (Cas Nuclease): Cas9, Cas12, Cas13, Other Cas Nucleases
2) By Guide Ribonucleic Acid (RNA): Single-guide RNA (sgRNA), Dual-guide RNA, Synthetic Guide RNA
3) By Deoxyribonucleic Acid (DNA) Ligase: T4 DNA Ligase, E. coli DNA Ligase, Other DNA Ligases
4) By Restriction Endonuclease: Type II Restriction Enzymes, Type I And III Restriction Enzymes, Other Restriction Enzymes
5) By Other Types: CRISPR Delivery Systems, CRISPR Plasmids, CRISPR-Based Diagnostic Tools

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15549

Which regions are key players in the growth of the crispr gene editing market?
North America was the largest region in the CRISPR gene editing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the CRISPR gene editing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the crispr gene editing market?
Major companies operating in the CRISPR gene editing market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., GenScript, Integrated DNA Technologies Inc., Takara Bio Inc., OriGene Technologies Inc., Intellia Therapeutics Inc., New England Biolabs, Synthego, Arbor Biotechnologies Inc., Rockland Immunochemicals Inc., Cellectis, Editas Medicine, Caribou Biosciences Inc., System Biosciences LLC, Applied StemCell, Addgene, Mirus Bio LLC, Excision BioTherapeutics Inc., GeneCopoeia Inc., ToolGen Inc., Cellecta Inc., CRISPR Therapeutics, ERS Genomics Limited

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15549&type=smp

What Is Covered In The CRISPR Gene Editing Global Market Report?

•Market Size Forecast: Examine the crispr gene editing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the crispr gene editing market for a structured understanding.
•Key Players Overview: Analyze major players in the crispr gene editing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the crispr gene editing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the crispr gene editing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the crispr gene editing market.
•Industry Challenges: Identify potential risks and obstacles affecting the crispr gene editing market.
•Competitive Landscape: Review strategic developments in the crispr gene editing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.